EUVIMEDEUVIMED entdecken
Crossref

Leukocyte telomere length and clinical characteristics in patients with type 2 diabetes mellitus with and without chronic kidney disease

Y. E. Rebrova, Y. A. Saienko, K. K. Midlovets, B. M. Mankovsky

The Ukrainian Biochemical Journal · 15.06.2026 · 98 (3) · 76-82

DOI: 10.15407/ubj98.03.076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Ukrainian Biochemical Journal, online erschienen am 15.06.2026. Verfasst von Y. E. Rebrova und 3 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Telomeric mechanisms are considered important contributors to chronic kidney disease progression in patients with type 2 diabetes mellitus, although data on telomere length in diabetic kidney disease remain limited.

Objective

To evaluate the relationship between telomere length and clinical characteristics in patients with type 2 diabetes mellitus with and without chronic kidney disease.

Methods

The study included 100 patients with T2DM, divided into two groups: 50 with and 50 without CKD. Routine clinical and biochemical blood tests were performed for all subjects. Leukocyte telomere length was assessed by quantitative real-time polymerase chain reaction following the method described by Cawthon.

Results

T2DM patients with CKD were significantly older, had a longer duration of diabetes, exhibited significantly lower estimated glomerular filtration rate (eGFR), higher urine albumin-to-creatinine ratio and frequency of cardiovascular complications compared with non-CKD patients. No significant correlations were found between telomere length and age, eGFR, albuminuria, or cardiovascular disease in either group. In patients with type 2 diabetes mellitus chronic kidney disease was associated with higher frequency of pathologically short telomeres (20.8%) versus non-CKD patients (2.1%), suggesting accelerated cellular aging in CKD independent of chronological age.

Conclusions

Shortened telomeres in patients with type 2 diabetes mellitus and chronic kidney disease may reflect accelerated cellular aging and could serve as an additional marker for biological risk stratification beyond traditional renal indicators. Keywords: cellular aging, chronic kidney disease, telomeres, type 2 diabetes mellitus

Zitieren

APA

Rebrova, Y. E., Saienko, Y. A., Midlovets, K. K., & Mankovsky, B. M. (2026). Leukocyte telomere length and clinical characteristics in patients with type 2 diabetes mellitus with and without chronic kidney disease. The Ukrainian Biochemical Journal, 98(3), 76-82. https://doi.org/10.15407/ubj98.03.076

Vancouver

Rebrova YE, Saienko YA, Midlovets KK, Mankovsky BM. Leukocyte telomere length and clinical characteristics in patients with type 2 diabetes mellitus with and without chronic kidney disease. The Ukrainian Biochemical Journal. 2026;98(3):76-82. doi:10.15407/ubj98.03.076

BibTeX
@article{Rebrova2026,
  author = {Rebrova, Y. E. and Saienko, Y. A. and Midlovets, K. K. and Mankovsky, B. M.},
  title = {Leukocyte telomere length and clinical characteristics in patients with type 2 diabetes mellitus with and without chronic kidney disease},
  journal = {The Ukrainian Biochemical Journal},
  year = {2026},
  volume = {98},
  number = {3},
  pages = {76--82},
  doi = {10.15407/ubj98.03.076}
}
Kostenlos starten →